Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1Phase 2 1

Status

Unknown 119Completed 101Recruiting 37Not yet recruiting 24Terminated 16Active not recruiting 11Withdrawn 7Suspended 4Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Colorectal Neoplasms 1

Interventions

Specimen Handling 29Magnetic Resonance Spectroscopy 18Biopsy 16Cyclophosphamide 15Nivolumab 10Paclitaxel 9Vincristine 8Cisplatin 8venetoclax 7Prednisone 7Gemcitabine 7Doxorubicin 7Bevacizumab 7Azacitidine 7pembrolizumab 6Radiotherapy 6Fluorouracil 6Etoposide 6Drug Therapy 6Docetaxel 6Rituximab 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Injections 5Everolimus 5Capecitabine 5fludarabine phosphate 4Taxes 4Surgical Procedures, Operative 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Suspended × Interventional × S 1 (combination) × Clear all
NCT00209729 2010-05-26

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Hokkaido Gastrointestinal Cancer Study Group

Phase 1/2 Suspended
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00209677 2007-11-01

Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 1/2 Suspended
40 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00316745 2007-11-01

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 3 Suspended
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00209664 2006-02-02

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 2 Suspended
40 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡